CorFlow Therapeutics is developing proprietary technologies for diagnosis and treatment of microvascular obstructions (MVO) in heart attack patients.
View Top Employees from CorFlow Therapeutics AG| Website | http://www.corflow-therapeutics.ch |
| Revenue | $5 million |
| Employees | 5 (5 on RocketReach) |
| Founded | 2016 |
| Address | Neuhofstrasse 3d, Baar, Zug 6340, CH |
| Phone | +41 41 399 18 00 |
| Technologies |
JavaScript,
HTML,
Bootstrap
+5 more
(view full list)
|
| Industry | Retail, Medical Devices, Medical, Health Care, Medical Device |
| SIC | SIC Code 384 Companies, SIC Code 38 Companies |
| NAICS | NAICS Code 339 Companies, NAICS Code 33 Companies |
Looking for a particular CorFlow Therapeutics AG employee's phone or email?
CorFlow Therapeutics AG Questions
The CorFlow Therapeutics AG annual revenue was $5 million in 2024.
5 people are employed at CorFlow Therapeutics AG.
CorFlow Therapeutics AG is based in Baar, Zug.
The NAICS codes for CorFlow Therapeutics AG are [339, 33].
The SIC codes for CorFlow Therapeutics AG are [384, 38].
Top CorFlow Therapeutics AG Employees
-
View
Bütler Markus
VP Quality Management and Regulatory Affairs at CorFlow Therapeutics AG
Merenschwand, Aargau, Switzerland -
1
-
1
Related Companies
